Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
El Saad Pharmaceutical Industries is a prominent Syrian pharmaceutical company headquartered in Aleppo. Established in 1992, the company has grown to become one of the largest manufacturers of generic medicines in the region. Its product portfolio covers a wide array of therapeutic categories, including anti-infectives, cardiovascular, gastrointestinal, and central nervous system treatments. El Saad operates advanced manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. Despite the regional challenges, the company maintains a strong presence in the Syrian market and continues to export its products to various countries across the Middle East and Africa. The company is recognized for its commitment to providing affordable, high-quality essential medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on El Saad company.